TNFSF14 and thyroid gland carcinoma: Finally, TNFSF14 or these mediating blood metabolites could be targeted therapeutically by developing inhibitors specifically directed at these inflammatory cytokines or blood metabolites, thereby aiding in the treatment of thyroid cancer and improving the prognosis of patients.